ONCOMATRYX Raises €25 Million for OMTX705 Clinical Trials

ONCOMATRYX, a biopharmaceutical company from Spain, secures funding for clinical trials of OMTX705.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here